A1I5A
quinaprilat
| Created: | 2025-03-03 |
| Last modified: | 2025-09-03 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 56 |
| Chiral Atom Count | 3 |
| Bond Count | 58 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | quinaprilat |
| Synonyms | (3S)-2-[(2S)-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid |
| Systematic Name (OpenEye OEToolkits) | (3~{S})-2-[(2~{S})-2-[[(2~{S})-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-3,4-dihydro-1~{H}-isoquinoline-3-carboxylic acid |
| Formula | C23 H26 N2 O5 |
| Molecular Weight | 410.463 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | C[CH](N[CH](CCc1ccccc1)C(O)=O)C(=O)N2Cc3ccccc3C[CH]2C(O)=O |
| SMILES | OpenEye OEToolkits | 2.0.7 | CC(C(=O)N1Cc2ccccc2CC1C(=O)O)NC(CCc3ccccc3)C(=O)O |
| Canonical SMILES | CACTVS | 3.385 | C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2Cc3ccccc3C[C@H]2C(O)=O |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)O)N[C@@H](CCc3ccccc3)C(=O)O |
| InChI | InChI | 1.06 | InChI=1S/C23H26N2O5/c1-15(24-19(22(27)28)12-11-16-7-3-2-4-8-16)21(26)25-14-18-10-6-5-9-17(18)13-20(25)23(29)30/h2-10,15,19-20,24H,11-14H2,1H3,(H,27,28)(H,29,30)/t15-,19-,20-/m0/s1 |
| InChIKey | InChI | 1.06 | FLSLEGPOVLMJMN-YSSFQJQWSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB14217 |
|---|---|
| Name | Quinaprilat |
| Groups | experimental |
| Description | The active metabolite of the prodrug [quinapril]. |
| Synonyms |
|
| Categories |
|
| CAS number | 82768-85-2 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL1733 |
| PubChem | 107994 |
| ChEMBL | CHEMBL1733 |
| ChEBI | CHEBI:140296 |














